Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

TOBRAMYCIN SULFATE

Standard Dose
EQ 1.2MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 063081 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TOBRAMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 1.2MG BASE/ML Sponsor HOSPIRA Submission history Latest submission status date: 2023-02-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 063081 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TOBRAMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 1.2MG BASE/ML Sponsor HOSPIRA Submission history Latest submission status date: 2023-02-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (TOBRAMYCIN SULFATE) | Drug Monograph | MedicHelpline